It’s not just about growth — it’s about what kind of growth. Whether you're a single-location practice considering your first exit, or a 30-location DSO aiming to attract private equity interest, preparing for acquisition requires more than profitability and a clean P&L. In today’s deal environment, buyers are scrutinizing scalability, infrastructure, technology adoption, and operational sophistication more than ever.
What buyers are prioritizing right now (and what’s a red flag)
The difference between a “practice” and a “platform” in the eyes of PE
How to build acquirer-ready infrastructure: finance, compliance, tech, reporting
How digital maturity, clinical consistency, and patient retention drive valuation
Scaling
Investment
Shalin Tejani
Chief Executive Officer
Legacy Dental Group
Join GATC Health for an interactive roundtable exploring how AI-driven predictive intelligence is transforming investment strategy in drug development and biotech financing. Discover how the technology platform used by Lloyd's of London is now driving Derisq™ - a new report that delivers validated predictions of safety, efficacy, and non-obvious risk - predicting 11x more accurately than clinical trial outcomes - to provide confidence well before clinical trials begin.
In this session, investors and biopharma leaders will learn how:
- Predictive AI platforms can de-risk portfolios and prioritize high-probability assets
- Detailed predictions (91% specificity, 86% sensitivity) to drive capital efficiency and strategic decision-making
- Innovative risk mitigation approaches, including insurance-backed clinical outcomes through partnerships with Lloyd's of London, are creating new pathways to secure funding
Walk away with actionable insights on leveraging detailed predictive reports that deliver deep insights into unknown risk within 3-4 weeks to support your investment thesis and development strategy - reducing uncertainty and accelerating success.
V. Tyrone Lam
Chief Business Officer
GATC Health
V. Tyrone Lam
Chief Business Officer
GATC Health
Today’s patients expect Amazon-like speed — even in healthcare. DSOs that can deliver fast, efficient, and high-quality clinical care win on both patient satisfaction and operational efficiency. This session explores how leading DSOs are re-engineering clinical operations to deliver same-day crowns, aligners, implants, and diagnostics, while maintaining consistency and clinical excellence across multiple locations.
Which procedures are best suited for same-day delivery and how to price/package them
What equipment enables speed — from chairside milling to CBCTs, 3D printers, and intraoral scanners
How to create standardized protocols that balance speed, staff accountability, and clinical accuracy
Service Innovation
Dr Sima Yakoby Epstein
Chief Executive Officer
OrthoNu
James Wilcox
Senior Director of Sales
Medit
Kamylla Bullard
Regional Sales Manager
Medit
Specialty services such as implants, endodontics, periodontics, sleep apnea treatments, and orthodontics offer a direct path to revenue diversification, deeper patient retention, and higher lifetime value — while also positioning the brand as a full-service provider.
This session explores how mid-sized DSOs are strategically bringing specialties in-house instead of relying on external referrals, and how they’re managing the operational, clinical, and financial complexity of doing so.
What services offer the highest profit margins, patient loyalty gains, and scalability by region/population density
How to recruit, retain, and onboard in-house specialists across implantology, endo, ortho, and more
Equipment and platform investments needed to launch and scale specialty lines
Service Innovation
Phillip Matousek
Chief Operating Officer
Lumio Dental